We report the long-term results of a prospective randomized study on the use of
ursodeoxycholic acid (UDCA) for prevention of hepatic complications after allogeneic stem …

The role of ursodeoxycholic acid (UDCA) in the prevention of hepatic complications after
allogeneic stem cell transplantation was studied in a prospective randomized open-label …

Hepatic veno-occlusive disease (HVOD) is a serious life-threatening complication of
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …

Acute rejection following orthotopic liver transplantation is a common problem despite
current immunosuppressive regimens. Ursodeoxycholic acid (UDCA) has been shown in …

Background. Prophylactic treatment with ursodeoxycholic acid (UDCA) has been reported to
reduce the incidence of acute rejection after liver transplantation compared with historical …

Acute cellular rejection (ACR) after orthotopic liver transplantation occurs in 50% to 80% of
patients despite the recent advances in immunosuppressive therapy. Adjuvant use of …

Hepatic veno‐occlusive disease (VOD) is a common transplant‐related complication of stem
cell transplantation. There is no safe and proven therapy for established VOD, and attempts …

Objectives: Data regarding the long‐term treatment of ursodeoxycholic acid (UDCA) in
individuals of chronic graft‐vs.‐host disease (cGVHD) of the liver are limited. The aims of this …

Ursodiol is a hydrophilic, non-hepatotoxic bile salt indicated for the medical treatment of
cholesterol gallstones. This pilot study explored the use of prophylactic ursodiol in an …

Background/Aims: Acute rejection is still a major problem after liver transplantation.
Ursodeoxycholic acid has beneficial effects in cholestasis by reducing the expression of …